Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Single-cell multi-omics dissection of c-Myb/AURKA-mediated autophagy and metabolic reprogramming in diabetic adipose-derived stem cells.

Yin Y., Shao W., Zha W., Wang B.

Prospective Study on Diabetic Foot, Chronic Inflammation, published in Front Immunol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Front Immunol (2025)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
41080535
PMCID
PMC12507903
DOI
10.3389/fimmu.2025.1665909

Abstract (original English)

Background Diabetes mellitus (DM) alters the functional properties of adipose-derived stem cells (ADSCs), contributing to impaired tissue repair in diabetic foot ulcers (DFUs), a condition characterized by chronic inflammation. Although multi-omics studies have identified metabolic dysregulation in DM, the transcriptional and metabolic networks underlying ADSCs dysfunction remain elusive. Here, we integrated single-cell transcriptomics and metabolic profiling to characterize DM-associated ADSCs subpopulations and explored the effects of high glucose (HG)-induced inflammatory stress on autophagy, apoptosis, and metabolic reprogramming. Methods We analyzed single-cell RNA sequencing (scRNA-seq) data from ADSCs of three DM patients and three healthy donors. Subpopulations were clustered using Seurat, and functional annotations were performed via enrichment analysis. Autophagy, apoptosis, and metabolic pathways were assessed using AUCell scoring. Experimental validation was conducted using HG-treated ADSCs, including c-Myb/AURKA overexpression/knockdown, Co-IP, ChIP, and dual-luciferase reporter assays. Results We identified fourteen ADSCs subpopulations, among which C5 (TOP2A High), C8 (AURKA High), C9 (CCNB1 High), and C11 (MMP3 High) exhibited G2/M phase preference and enhanced stemness (C11) or proliferation (C8) in DM. HG induced autophagy in ADSCs via c-Myb/AURKA pathway to r

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansAutophagySingle-Cell AnalysisAurora Kinase AProto-Oncogene Proteins c-mybAdipose TissueDiabetes MellitusStem CellsApoptosisCellular Reprogramming

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research